Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022
Cash & Equivalents	53.97	30.63	61.58	9.24	20.99	55.89
Short-Term Investments	216.96	114.11	165.34	-	22.76	-
Cash & Short-Term Investments	270.93	144.74	226.92	9.24	43.76	55.89
Cash Growth	27.98%	-36.22%	2356.33%	-78.89%	-21.71%	-12.44%
Accounts Receivable	0.06	0.01	0.12	1.17	1.36	1.61
Other Receivables	-	-	-	-	6.11	-
Total Trade Receivables	0.06	0.01	0.12	1.17	7.47	1.61
Inventory	-	-	-	-	-	1.4
Other Current Assets	4.37	3.65	4.13	6.43	1.99	0.44
Total Current Assets	275.35	148.39	231.16	16.84	53.22	59.33
Net Property, Plant & Equipment	94.93	78.1	59.54	6.32	0.37	2.49
Other Intangible Assets	40	40	50	50	-	-
Goodwill	-	-	-	24.06	-	-
Other Long-Term Assets	0.49	0.49	0.41	0.67	4.51	2.62
Total Assets	410.77	266.97	341.1	97.89	58.09	64.44

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022
Accounts Payable	26.49	20.51	10.34	6.91	1.54	0.97
Accrued Expenses	3.88	7.49	5.48	3.59	1.3	1.03
Current Portion of Long-Term Debt	0.06	0.06	0.05	0.05	-	-
Current Portion of Leases	1.07	0.62	0.96	0.05	-	0.27
Unearned Revenue	-	-	1.4	-	-	-
Other Current Liabilities	-	-	-	5.07	0.28	-
Total Current Liabilities	31.49	28.68	18.23	15.66	3.12	2.27
Long-Term Debt	1.55	1.57	1.63	1.68	-	-
Long-Term Leases	1.55	1.01	1.43	0.78	-	0.26
Other Long-Term Liabilities	28.74	28.69	29.15	4.59	0.33	0.64
Total Long-Term Liabilities	31.85	31.26	32.2	7.05	0.33	0.9
Total Liabilities	63.33	59.94	50.43	22.71	3.45	3.16

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022
Common Stock	0.11	0.07	0.07	0.03	0.14	0.14
Additional Paid-in Capital	708.58	541.69	522.37	227.59	160.43	159.73
Accumulated Other Comprehensive Income	-0.23	0.11	-0.05	-	-	-
Retained Earnings	-361.03	-334.84	-231.72	-152.44	-105.93	-98.6
Shareholders' Equity	347.44	207.03	290.67	75.18	54.64	61.28
Total Liabilities & Equity	410.77	266.97	341.1	97.89	58.09	64.44

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022
Total Debt	4.23	3.25	4.06	2.55	0	0.52
Net Cash (Debt)	266.7	141.48	222.85	6.69	43.76	55.37
Net Cash Growth	28.29%	-36.51%	3232.64%	-84.72%	-20.97%	-12.19%
Net Cash Per Share	3.27	1.92	3.46	0.25	3.08	3.90
Book Value	347.44	207.03	290.67	75.18	54.64	61.28
Book Value Per Share	4.26	2.80	4.51	2.81	3.85	4.32
Tangible Book Value	307.44	167.03	240.67	1.12	54.64	61.28
Tangible Book Value Per Share	3.77	2.26	3.74	0.04	3.85	4.32

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 11, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error